ZYDUS LIFESCIENCES
|
The Current P/S Ratio of ZYDUS LIFESCIENCES is 4.90.
Share Price | ₹1,004.3 | Nov 04,2024 |
Market Cap | ₹101,052.7 Cr | |
Sales-TTM | ₹20,615.3 Cr | TTM-Consolidated Results |
Price/Sales | 4.90x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of ZYDUS LIFESCIENCES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹101,052.7 Cr] as on Nov 04,2024
(/) Sales [ ₹20,615.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.90x ]
Thus, for ZYDUS LIFESCIENCES , the investors are currently willing to pay '4.90 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ZYDUS LIFESCIENCES !
The chart below summarizes the trend in P/S Ratio of ZYDUS LIFESCIENCES over the last five years.
Historical PS (Price/Sales) ratio chart of ZYDUS LIFESCIENCES
PS Ratio Performance Analysis for ZYDUS LIFESCIENCES
- ZYDUS LIFESCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.09x.
- ZYDUS LIFESCIENCES 's operated at median p/e ratio of 2.89x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ZYDUS LIFESCIENCES 's p/e ratio peaked in Mar2024 at 5.17x.
- ZYDUS LIFESCIENCES 's p/e ratio hit its five-year low in Mar2020 of 1.92x.
How does ZYDUS LIFESCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
ZYDUS LIFESCIENCES | 20,615.3 | 4.90 | 101,052.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.63 | 433,992.0 |
CIPLA LTD | 26,512.0 | 4.83 | 127,968.0 |
DR REDDYS LABORATORIES LTD | 28,949.3 | 3.65 | 105,796.0 |
DIVIS LABORATORIES LTD | 8,185.0 | 19.12 | 156,498.0 |
MANKIND PHARMA LTD | 10,649.6 | 10.29 | 109,574.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 9.64 | 108,250.0 |
LUPIN LTD | 20,797.1 | 4.80 | 99,847.4 |
AUROBINDO PHARMA LTD | 29,718.4 | 2.75 | 81,733.3 |
ABBOTT INDIA LTD | 5,927.5 | 10.56 | 62,599.5 |
ALKEM LABORATORIES LTD | 12,731.7 | 5.44 | 69,302.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ZYDUS LIFESCIENCES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.75x |
Max industry PS | 19.12x |
Median industry PS | 5.44x |
Average industry PS | 7.69x |
You may also like the below Video Courses